A New Trend Lung Cancer Treatment At Novaritis Globally known pharmaceutical company Novartis from Germany has stated using the strategy of treating lung cancer patients in a very unique way. The company is offering the best curing solution to these cancer sufferers who are facing the dreadly disease cancer in the lungs. Commonly known as NVS, this pharmaceutical company has been assisting these patients in distributing the right medicine in the local markets. More importantly the firm has been successful in making the right research and developmental efforts with a real quest of treating the lung cancer through advanced techniques. The firm has brought the brand Zykadia the right drug which was approved and certified by the US for curing the cancer in the lungs. This approval was dome in April last year. Interestingly this branded drug is yet to be approved by the European Union. As per the NVS sources the approval from the European Union will be in the offing as it awaits the final
http://cancerinlungs.com/novaritis-launches-a-new-lung-cancer-therapy/
No comments:
Post a Comment